What is it?

BlockRx is a series of initiatives by iSolve which leverage the Blockchain and iSolve’s Advanced Digital Ledger Technology™ (ADLT™). The platform is a comprehensive solution to fully integrate Life Science Researchers, BioPharma, Medical Device Manufactures, and Healthcare Providers to improve Patient Outcomes.

Official Explainer Video

BlockRx Details

Blockchain Ethereum (ERC20)
Proof Type Proof of Stake (PoS)
Team Location Pennsylvania, USA
First Announced July 10, 2017

ICO Details

Status | Crowdsale Ended
Registration Required
ICO Start Date Oct 13, 2017 | 10:00 am UTC
ICO End Date Jan 31 | 11:00 pm UTC
Soft Cap no soft cap
Hard Cap $300,000,000 USD
Contribution Size Min: 1 ETH
Total Supply 300,000,000 BKRx
Investor Supply 120,000,000 BKRx
ICO Conversion

1 ETH = 187 BKRx
(Oct 13- Nov 2)
1 ETH = 170 BKRx
(Nov 3- Dec 2)
1 ETH = 150 BKRx
(Dec 3- Jan 2)
1 ETH = 130 BKRx
(Jan 3- Jan 31)

Supply Distribution

40% ICO Crowdsale
30% Founders and Charity Distribution
20% Reserve fund for Pharma Companies (not exchangeable)
10% Future employee benefits

BlockRx Founding Team

Gordon Tampol
Gordon Tampol

Chief Executive Officer

Darryl G Glover
Darryl G Glover

Chief Clinical Officer

Kasia Piskorska
Kasia Piskorska

Chief Financial Officer

Carlos Sanchez
Carlos Sanchez

Chief Technology Officer